Combinent Biomedical Systems

About:

Combinent Biomedical Systems focuses on the transvaginal delivery of drugs targeting women’s reproductive endocrinology disorders.

Website: http://www.combinentbiomedical.com

Twitter/X: doteasy

Top Investors: Cytyc, Commons Capital, Vimac Ventures

Description:

Combinent Biomedical Systems, Inc., a women's healthcare company, offers multi-segmented vaginal rings that allow the delivery of hydrophobic and hydrophilic molecules, proteins, and other large molecules. It focuses on transvaginal delivery of drugs targeting women's reproductive endocrinology disorders, as well as diabetes, obesity, and infectious diseases. Combinent Biomedical Systems, Inc. was incorporated in 2000 and is based in Lexington, Massachusetts.

Total Funding Amount:

$6.35M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Lexington, Massachusetts, United States

Founded Date:

2000-01-01

Contact Email:

info(AT)combinentbiomedical.com

Founders:

Peter Lanciano, William Crowley

Number of Employees:

1-10

Last Funding Date:

2012-10-02

IPO Status:

Private

Industries:

© 2025 bioDAO.ai